Fang Ye, Frutos Anthony G, Verklereen Ronald
Biochemical Technologies, Science and Technology Division, Corning Incorporated, Corning, NY 14831, USA.
Comb Chem High Throughput Screen. 2008 Jun;11(5):357-69. doi: 10.2174/138620708784534789.
G protein-coupled receptors (GPCRs) have been proven to be the largest family of druggable targets in the human genome. Given the importance of GPCRs as drug targets and the de-orphanization of novel targets, GPCRs are likely to remain the frequent targets of many drug discovery programs. With recent advances in instrumentation and understanding of cellular mechanisms for the signals measured, biosensor-centered label-free cell assay technologies become a very active area for GPCR screening. This article reviews the principles and potential of current label-free cell assay technologies in GPCR drug discovery.
G蛋白偶联受体(GPCRs)已被证明是人类基因组中最大的可成药靶点家族。鉴于GPCRs作为药物靶点的重要性以及新靶点的去孤儿化,GPCRs很可能仍然是许多药物研发项目的常见靶点。随着仪器技术的最新进展以及对所测信号细胞机制的理解,以生物传感器为中心的无标记细胞检测技术成为GPCR筛选中一个非常活跃的领域。本文综述了当前无标记细胞检测技术在GPCR药物研发中的原理和潜力。